Yunyi Wu
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Crosstalk of thioredoxin system and programmed cell death: from pathophysiology to novel therapy.
Journal: Redox biology
Published: March 19, 2026
Lonidamine ameliorates MASH by reducing SREBP1 and inhibiting the MAPK pathway.
Journal: Acta biochimica et biophysica Sinica
Published: March 06, 2026
PROTAC-mediated regulation of programmed cell death: From molecular mechanisms to therapeutic breakthroughs.
Journal: Innovation (Cambridge (Mass.))
Published: September 11, 2025
Ferredoxins: master regulators in mitochondrial redox homeostasis and programmed cell death.
Journal: Redox biology
Published: August 14, 2025
Hydrogen sulfide regulation in redox homeostasis and programmed cell death: mechanistic insights and implications in cancer.
Journal: Journal of advanced research
Published: July 22, 2025
Protein lipoylation in cancer: metabolic reprogramming and therapeutic potential.
Journal: Cell death discovery
Published: March 01, 2025
Targeting epigenetic and post-translational modifications of NRF2: key regulatory factors in disease treatment.
Journal: Cell death discovery
Published: January 14, 2025
Molecular signatures of disulfidptosis: interplay with programmed cell death pathways and therapeutic implications in oncology.
Journal: Cellular & molecular biology letters
Published: October 29, 2024
Role of reactive oxygen species in myelodysplastic syndromes.
Journal: Cellular & molecular biology letters
Published: November 09, 2023
Last Updated: 09/26/2026